Bosh sahifaGRF • BME
add
Grifols SA Class A
Yopilish kursi
9,33 €
Kunlik diapazon
9,10 € - 9,40 €
Yillik diapazon
6,36 € - 15,92 €
Bozor kapitalizatsiyasi
5,54 mlrd EUR
Oʻrtacha hajm
3,42 mln
Narx/foyda
104,90
Dividend daromadliligi
-
Asosiy maydon
BME
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,77 mlrd | 3,32% |
Joriy xarajat | 463,74 mln | 5,21% |
Sof foyda | 55,99 mln | 178,99% |
Sof foyda marjasi | 3,16 | 170,09% |
Har bir ulushga tushum | — | — |
EBITDA | 334,62 mln | 48,68% |
Amaldagi soliq stavkasi | 26,24% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 646,04 mln | 11,59% |
Jami aktivlari | 21,44 mlrd | -0,43% |
Jami passivlari | 13,47 mlrd | 3,00% |
Umumiy kapital | 7,97 mlrd | — |
Tarqatilgan aksiyalar | 679,09 mln | — |
Narxi/balansdagi bahosi | 1,09 | — |
Aktivlardan daromad | 2,60% | — |
Kapitaldan daromad | 2,96% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 55,99 mln | 178,99% |
Operatsiyalardan naqd pul | 156,39 mln | 131,75% |
Sarmoyadan naqd pul | -141,88 mln | 1,48% |
Moliyadan naqd pul | 46,48 mln | -77,02% |
Naqd pulning sof oʻzgarishi | 45,35 mln | -33,70% |
Boʻsh pul | -1,10 mlrd | — |
Haqida
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories. Wikipedia
CEO
Tashkil etilgan
18-noy, 1940
Sayt
Xodimlar soni
23 744
